Detalhe da pesquisa
1.
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
N Engl J Med
; 381(9): 841-851, 2019 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31185157
2.
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30-week, double-blind, phase 3a, randomized trial.
Diabetes Obes Metab
; 23(2): 404-414, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33074557
3.
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
N Engl J Med
; 375(19): 1834-1844, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27633186
4.
Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial.
Diabetes Obes Metab
; 21(6): 1455-1463, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30821053
5.
Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre-specified analysis of the Chinese population from the BERSON clinical trial.
Diabetes Obes Metab
; 21(6): 1464-1473, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30851062
6.
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial.
Lancet Diabetes Endocrinol
; 12(3): 184-195, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330988
7.
BrazIliaN Type 1 & 2 DiabetEs Disease Registry (BINDER): longitudinal, real-world study of diabetes mellitus control in Brazil.
Front Clin Diabetes Healthc
; 3: 934629, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992732
8.
Advances in GLP-1 treatment: focus on oral semaglutide.
Diabetol Metab Syndr
; 13(1): 99, 2021 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34526121
9.
Barriers to insulin initiation in elderly patients with type 2 diabetes mellitus in Brazil.
Diabetes Metab Syndr
; 12(1): 39-44, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28864058
10.
Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial.
Clin Cardiol
; 41(9): 1117-1122, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29962050
11.
Beneficial effects of prolactin and laminin on human pancreatic islet-cell cultures.
Mol Cell Endocrinol
; 263(1-2): 120-33, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17081683
12.
Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride.
Arch Med Res
; 37(4): 495-501, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16715577
13.
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from Latin America.
Curr Med Res Opin
; 32(3): 427-39, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26579834
14.
Starting glargine in insulin-naïve type 2 diabetic patients based on body mass index is safe.
World J Diabetes
; 5(1): 69-75, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24567803
15.
Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system.
Rev Assoc Med Bras (1992)
; 58(3): 294-301, 2012.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-22735220
16.
Islet versus pancreas transplantation in Brazil: Defining criteria for pancreas allocation decision.
Islets
; 3(6): 352-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21983190
17.
Comparison of prandial AIR inhaled insulin alone to intensified insulin glargine alone and to AIR insulin plus intensified insulin glargine in patients with type 2 diabetes previously treated with once-daily insulin glargine.
Diabetes Technol Ther
; 11 Suppl 2: S63-73, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19772451
18.
Efficacy of insulin glargine and glimepiride in controlling blood glucose of ethnic Japanese patients with type 2 diabetes mellitus.
Diabetes Res Clin Pract
; 79(1): 97-102, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17919763
19.
Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.
Diabetes Care
; 31(9): 1723-8, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18535196
20.
Custo-efetividade e impacto orçamentário da saxagliptina como terapia adicional à metformina para o tratamento do diabetes mellitus tipo 2 no sistema de saúde suplementar do Brasil / Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the brazilian private health system
Rev. Assoc. Med. Bras. (1992)
; 58(3): 294-301, May-June 2012. tab
Artigo
em Português
| LILACS | ID: lil-639552